Dyslipidemia

There are 2,317 papers on dyslipidemia in aging research: 130 trials and 1,386 observational studies in people, 126 in animals, 1 in cells, 626 reviews. The newest story, Nov 16, 2026: “Diagnosed blood fat disorder linked to environment in China”.

Disease

2,317 papers study it874 more mention it461 findings

371 new papers in 30 daysSee all 3,191 papers on dyslipidemia

“Dyslipidemia and serum calcium levels were significant predictors of TPTD discontinuation”
Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05Journal of bone and mineral metabolism2025doi:10.1007/s00774-025-01610-1
  • Human trial130
  • Humans1,386
  • Animals126
  • Cells1
  • In silico14

Interventions

39

Single anastomosis sleeve ileal bypass

downin humans1−86% remission

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower dyslipidemia in humans (Primary metabolic and bariatric surgery) (85.6% remission).

    “Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively.”

    HumansPrimary metabolic and bariatric surgery

    Single-center experience with sasi bypass: mid-term outcomes and technical evolution

    Langenbeck's archives of surgery

More on Single anastomosis sleeve ileal bypass

Clozapine

no changein humans1

1 study
  1. Clozapine was not clearly linked with dyslipidemia in humans (Schizophrenia; compared with non-clozapine antipsychotic users).

    “4,783 ClozUs had risks of MACE, diabetes, and dyslipidemia comparable to Non-ClozUs”

    HumansSchizophrenia; compared with non-clozapine antipsychotic usersMean follow-up 12.78 yearsn = 19,132

    Long-Term Metabolic Risk Associated with Clozapine in People with Schizophrenia: A Population-based Study in Hong Kong

    Research SquarePreprint

More on Clozapine

Lacticaseibacillus paracasei

downin mice1

1 study
  1. Lacticaseibacillus paracasei decreases dyslipidemia in mice (HFD-induced obesity following semaglutide withdrawal).

    “L. paracasei LP-18 also ameliorated dyslipidemia”

    AnimalsHFD-induced obesity following semaglutide withdrawalLP-184 weeks

    Lacticaseibacillus paracasei LP-18 Alleviates Post-Semaglutide Weight Rebound and Metabolic Dysfunction in Obese Mice

    Metabolites

More on Lacticaseibacillus paracasei

Intestinal bipartition

downin humans1−75% remission

1 study
  1. Intestinal bipartition is linked with lower dyslipidemia in humans (75% remission).

    “remission rates were 58.5% for hypertension, 34.2% for type 2 diabetes (50% improved), 76.1% for OSAS, and 75% for dyslipidemia.”

    Humans12 months

    Different intestinal bipartition procedures: early retrospective results from a multicenter Italian experience in 202 patients

    Updates in surgery

More on Intestinal bipartition

Ultra-processed foods

no changein humans1

1 study
  1. Ultra-processed foods were not clearly linked with dyslipidemia in humans (adjusted model).

    “food consumption, according to the NOVA classification, was not associated with changes in the lipid profile of CUME participants over the four-year follow-up period.”

    Humansadjusted modelfour yearsn = 2,771

    Association between food consumption based on the degree of processing and dyslipidemia in Brazilian adults (CUME study)

    Ciencia & saude coletiva

More on Ultra-processed foods

Euterpe oleracea

downin rats1

1 study
  1. Euterpe oleracea decreases dyslipidemia in rats (ovariectomized rats).

    “ASE attenuated OVX-induced alterations in body fat mass, dyslipidemia, leptin, and total T3;”

    Animalsovariectomized ratsseed extract200 mg/kg/day8 weeks

    Açaí seed extract attenuates metabolic dysfunction and adipocyte hypertrophy by improving oxidative and inflammatory status in ovariectomized rats

    Nutrition research (New York, N.Y.)

More on Euterpe oleracea

Zinc

downin rats1

1 study
  1. Zinc decreases dyslipidemia in diabetic rats (high-fat diet plus STZ).

    “ZnSO4 significantly ameliorated systemic dyslipidemia.”

    Animalsin diabetic rats (high-fat diet plus STZ)10 mg/kg/day4 weeksfemales

    Neuroprotective Effects of Zinc Sulfate Against Type 2 Diabetes-Induced Encephalopathy in Aged Rats

    International journal of molecular sciences

More on Zinc

Lifestyle modification program

downin humans1

1 study
  1. Lifestyle modification program decreases dyslipidemia in humans (menopause transition).

    “Evidence-based lifestyle interventions, such as Mediterranean and Dietary Approaches to Stop Hypertension (DASH) dietary patterns along with regular aerobic or resistance training, can help mitigate these adverse lipid changes.”

    Reviewmenopause transitionfemales

    Dyslipidemia across the menopause transition: Mechanisms, trajectories, and opportunities for cardiovascular prevention

    Maturitas

More on Lifestyle modification program

Smoking

upin humans1

1 study
  1. Smoking is linked with higher dyslipidemia in diabetic individuals.

    “Furthermore, smoking worsened these lipid irregularities.”

    Humansin diabetic individuals

    Relationship between metabolic parameters and lifestyle factors in type 2 diabetes mellitus: a retrospective analysis

    International Journal of Research in Medical Sciences

More on Smoking

Dietary pattern

downin humans1

1 study
  1. Dietary pattern decreases dyslipidemia in humans (postmenopausal women).

    “Nutritional interventions aimed at modulating the gut microbiota—including Mediterranean, plant-based, and DASH dietary patterns, increased dietary fiber intake, and supplementation with prebiotics, probiotics, polyphenols, phytoestrogens, and omega-3 fatty acids—have shown potential to improve lipid profiles”

    Reviewpostmenopausal women

    The Role of Gut Microbiota in Postmenopausal Women: Implications for Lipid Metabolism and Targeted Nutritional Interventions

    Current nutrition reports

More on Dietary pattern

All 39

Effects

19

Cognitive function

downin humans2RR 1.3

2 studies
  1. Dyslipidemia is linked with worse cognitive function in humans.

    “CU individuals with dyslipidemia showed faster decline in z-scores of all domains, i.e., memory, language, attention/executive function, visuospatial and global cognition relative to CU individuals without dyslipidemia.”

    Humansmedian 6.4 yearsn = 4,236

    The longitudinal association between dyslipidemia and cognitive trajectory

    Journal of Alzheimer's disease : JAD

  2. Dyslipidemia is linked with worse cognitive function in humans (community-dwelling older adults) (RR 1.30, 95% CI 1.07-1.57).

    “while dyslipidemia was only associated with low performance (RR: 1.30, 95%CI: 1.07-1.57).”

    Humanscommunity-dwelling older adults

    Potential modifiable factors associated with late-life cognitive trajectories

    Frontiers in neurology

Atherosclerosis

upin reviews1

1 study
  1. Dyslipidemia increases atherosclerosis.

    “Such lipid abnormalities contribute to accelerated atherosclerosis and early renal deterioration.”

    Review

    Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome

    International journal of molecular sciences

More on Atherosclerosis

White matter lesions

upin humans1

1 study
  1. Dyslipidemia is linked with higher white matter lesions in humans (stratified by age) (β = 154.0, 95% CI 93.0-215.0).

    “For both diabetes and dyslipidemia, the WML volume increased in those aged <50 years (β [95%CI] = 376.5 [209.3-543.8] and β [95%CI] = 154.0 [93.0-215.0], respectively).”

    Humansstratified by agebrainn = 4,595

    Association between cardiovascular disease risk factors and white matter lesions: The Tohoku Medical Megabank Cohort Study

    Journal of atherosclerosis and thrombosis

Hypertension

mediatesin humans1

1 study
  1. Dyslipidemia is linked with hypertension in humans (indirect effect) (indirect effect = -0.017, 95% CI -0.033 to -0.006).

    “Dyslipidemia mediated CCR/WC’s effect on hypertension (indirect effect=-0.017; 95%CI: -0.033 to -0.006).”

    Humansindirect effectn = 7,117

    The CCR/WC ratio as a predictor of dyslipidemia and Its mediating effect on hypertension in middle-aged and older adults

    BMC cardiovascular disorders

More on Hypertension

Presbycusis

no changein humans1

1 study
  1. Dyslipidemia was not clearly linked with presbycusis in humans (PROLANIS patients) (p=0.413).

    “significant association for hypertension (p=0.000) and diabetes mellitus (p=0.006), but not for dyslipidemia (p=0.413)”

    HumansPROLANIS patientsn = 44

    Association Between Systemic Disease And Presbycusis Among Patients Of Chronic Disease Management

    International Journal of Health Engineering and Technology

More on Presbycusis

Stroke-related mortality

upin humans1

1 study
  1. Dyslipidemia is linked with higher stroke-related mortality in patients with dyslipidemia (from 0.5 in 1999 to 2.97 in 2023 (AAPC: 7.47; 95% CI: 6.54 to 8.40, p < 0.01)).

    “The AAMR observed a significantly steep incline from 0.5 in 1999 to 2.97 in 2023 (AAPC: 7.47; 95% CI: 6.54 to 8.40, p < 0.01).”

    Humansin patients with dyslipidemia

    Rising mortality and post-COVID shifts due to stroke in adults with dyslipidemia in the U.S. from 1999 to 2023: analysis of the CDC WONDER database

    The International journal of neuroscience

Handgrip strength

downin humans1

1 study
  1. Dyslipidemia is linked with worse handgrip strength in people with type 2 diabetes.

    “In women with diabetic dyslipidemia, handgrip strength was significantly lower.”

    Humansin people with type 2 diabetesfemales

    Skeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia

    Lipids in health and disease

6-minute walk distance

downin humans1

1 study
  1. Dyslipidemia is linked with worse 6-minute walk distance in people with type 2 diabetes matched for diabetes duration (p < 0.05).

    “higher body fat percentage, and reduced 6MWD compared to those with diabetes alone (p < 0.05).”

    Humansin people with type 2 diabetes matched for diabetes duration

    Skeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia

    Lipids in health and disease

Skeletal muscle mass

downin humans1

1 study
  1. Dyslipidemia is linked with lower skeletal muscle mass in people with type 2 diabetes matched for diabetes duration (p < 0.05).

    “people with diabetic dyslipidemia showed significantly lower skeletal muscle mass and skeletal muscle index (SMI)”

    Humansin people with type 2 diabetes matched for diabetes duration

    Skeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia

    Lipids in health and disease

Stroke

mediatesin humans1

1 study
  1. Dyslipidemia is linked with stroke in humans (free of diabetes) (8.92%).

    “association between stable high CTI and stroke was partially mediated by hypertension (19.36 %) and dyslipidemia (8.92 %).”

    Humansfree of diabetesn = 5,973

    Change in C-reactive protein-triglyceride glucose index and risk of stroke among middle-aged and older adults free of diabetes: A national cohort study

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Stroke

All 19

Upstream

18

Menopause

upin humans2

2 studies
  1. Menopause is linked with higher dyslipidemia in humans.

    “Postmenopausal women exhibited higher total cholesterol, LDL, beta lipoprotein, and triglyceride levels, while HDL levels were significantly lower compared to the premenopausal group.”

    Humansfemales

    Estimation of cardio metabolic changes in menopausal transition a comparative study

    International Journal of Clinical Obstetrics and Gynaecology

  2. Menopause is linked with higher dyslipidemia in hypothyroid women (p<0.05).

    “These lipid abnormalities were more pronounced in post-menopausal hypothyroid women, particularly TG, VLDL, and HDL-C (p<0.05).”

    Humansin hypothyroid womenserumfemalesn = 150

    Effect of hypothyroidism on lipid profile in pre- and post-menopausal women in Erbil city

    Qalaai Zanist Scientific Journal

Inflammation

mediatesin humans2

2 studies
  1. Inflammation is linked with dyslipidemia in humans (OH-PAH associations with HyperTC/HyperTG in the U.S. population) (mediation proportions: 1.26 %-27.60 %).

    “Mediation analysis showed LMR, monocytes, and lymphocytes mediated OH-PAH associations with HyperTC/HyperTG in the U.S. population (mediation proportions: 1.26 %-27.60 %).”

    HumansOH-PAH associations with HyperTC/HyperTG in the U.S. populationfemalesn = 1,567

    Association between polycyclic aromatic hydrocarbon exposure and dyslipidemia in women: Evidence from two population-based studies and the mediating role of inflammation

    Ecotoxicology and environmental safety

  2. Inflammation is linked with dyslipidemia in humans (multi-omics profiling with causal inference and pathway analysis).

    “Multi-omics indicated that the associations were mediated by endogenous biomolecules and pathways, primarily pertinent to CVD, inflammation, and metabolism.”

    Humansmulti-omics profiling with causal inference and pathway analysisn = 76

    Exposome-Wide Ranking to Uncover Environmental Chemicals Associated with Dyslipidemia: A Panel Study in Healthy Older Chinese Adults from the BAPE Study

    Environmental health perspectives

More on Inflammation

STING1

downin humans1

1 study
  1. STING1 is linked with lower dyslipidemia in humans (carriers of R71H, G230A and R293Q alleles).

    “carriers of R71H, G230A and R293Q alleles were associated with a lower prevalence of dyslipidemia”

    Humanscarriers of R71H, G230A and R293Q alleles

    Hypomorphic STING1/TMEM173 variants may support immuno-metabolic resilience in aging people living with HIV

    GeroScience

More on STING1

Kidney dysfunction

upin reviews1

1 study
  1. Kidney dysfunction increases dyslipidemia.

    “In turn, kidney dysfunction further amplifies lipid abnormalities.”

    Review

    Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome

    International journal of molecular sciences

More on Kidney dysfunction

Insulin resistance

upin reviews1

1 study
  1. Insulin resistance increases dyslipidemia in obese patients.

    “chronic inflammation and insulin resistance further exacerbating the abnormalities”

    Reviewin obese patients

    Pharmacological Management of Dyslipidemia in Obese and Elderly Patients: Challenges, Current Therapies, and Emerging Treatments

    Journal of Applied Pharmaceutical Science

More on Insulin resistance

Hypertension

upin humans1

1 study
  1. Hypertension is linked with higher dyslipidemia in humans.

    “Dyslipidemia prevalence increased with worsening glycemic status, rising body mass index (BMI), and the presence of hypertension”

    Humansbloodn = 23,665

    Prevalence of dyslipidemia in India: The ICMR-INDIAB National Study (ICMR-INDIAB-25)

    Journal of clinical lipidology

More on Hypertension

Obesity

upin humans1

1 study
  1. Obesity is linked with higher dyslipidemia in humans.

    “Dyslipidemia prevalence increased with worsening glycemic status, rising body mass index (BMI), and the presence of hypertension”

    Humansbloodn = 23,665

    Prevalence of dyslipidemia in India: The ICMR-INDIAB National Study (ICMR-INDIAB-25)

    Journal of clinical lipidology

More on Obesity

Body mass index

no changein humans1

1 study
  1. Body mass index was not clearly linked with dyslipidemia in humans (Perimenopausal and postmenopausal women).

    “Age and duration since menopause showed significant association with dyslipidemia, while BMI and menopausal status did not.”

    HumansPerimenopausal and postmenopausal womenfemalesn = 257

    Study of serum lipid profile in relation to menopausal status and body mass index in a tertiary care hospital

    International Journal of Clinical Obstetrics and Gynaecology

More on Body mass index

CCDC63

no changein humans1

1 study
  1. CCDC63 was not clearly linked with dyslipidemia in non-drinkers (p > 0.05).

    “However, no such genetic associations were observed in the non-drinking group (p > 0.05 for all traits).”

    Humansin non-drinkers

    Genetic Influence of CCDC63 Polymorphisms on Alcohol-Induced Dyslipidemia in a Korean Cohort

    International journal of molecular sciences

More on CCDC63

Age

upin humans1

1 study
  1. age is linked with higher dyslipidemia in humans.

    “higher prevalence of dyslipidemia (p=0,001)”

    Humans

    Age-related characteristics of metabolic phenotypes and proinflammatory status in patients with normal and overweight body mass

    Advances in gerontology = Uspekhi gerontologii

All 18

Associations

283

Hypertension

upin humans15mixedin humans1OR 1.238–3.79

16 studies
  1. Dyslipidemia is associated with hypertension in humans (Multivariable analysis in older adults in China) (OR = 1.378, 95% CI 1.218–1.559).

    “dyslipidaemia (OR = 1.378, 95% CI 1.218–1.559) were positively correlated with hypertension”

    HumansMultivariable analysis in older adults in Chinan = 7,733

    High blood pressure often uncontrolled in older Chinese adults

    Scientific reports

  2. Hypertension is associated with dyslipidemia in humans (AOR 1.81 (95% CI: 1.14-2.90)).

    “presence of hypertension (AOR = 1.81, 95% CI: 1.14-2.90) were independently associated with increased odds of dyslipidemia.”

    Humans

    Prevalence of Dyslipidemia and Associated Factors Among Adult Outpatients at Jimma Medical Center, Southwest Ethiopia: A Cross-Sectional Study

    Health science reports

  3. Hypertension is linked with a higher risk of dyslipidemia in humans (sex-stratified models).

    “hypertension, diabetes, and abdominal obesity were consistently associated with higher odds of dyslipidemia in both sexes.”

    Humanssex-stratified modelsn = 7,803

    Sex-Specific Prevalence and Associated Factors of Dyslipidemia in Korean Adults: A Cross-Sectional Study

    Health science reports

  4. Dyslipidemia is associated with hypertension in humans (Prospective Hajj pilgrims in West Sumatra Province) (POR=1.68; 95% CI: 1.45–1.94).

    “dyslipidemia (POR=1.68; 95% CI: 1.45–1.94; p<0.001)”

    HumansProspective Hajj pilgrims in West Sumatra Province

    Risk Factors for Hypertension Among Prospective Older Hajj Pilgrims in West Sumatra Province in 2025

    Jurnal Kesmas (Kesehatan Masyarakat) Khatulistiwa

  5. Hypertension is associated with dyslipidemia in humans (postmenopausal women aged 65 years or younger) (p < .001).

    “hypertension diagnosis (p < .001),diabetes mellitus (p < .001)”

    Humanspostmenopausal women aged 65 years or youngerfemales

    Factors Associated with Dyslipidemia among Korean Postmenopausal Women: Analysis of the 2023 KNHANES IX-2

    Asia-pacific Journal of Convergent Research Interchange

  6. Hypertension is associated with dyslipidemia in humans (Overweight or obese patients with prediabetes; hypertensive versus non-hypertensive) (3.6-fold higher risk).

    “Hypertensive patients had a 3.6-fold higher risk of dyslipidemia”

    HumansOverweight or obese patients with prediabetes; hypertensive versus non-hypertensiven = 104

    Study of dyslipidemia in overweight and obese patients with prediabetes

    Vietnam Journal of Diabetes and Endocrinology

  7. Hypertension is linked with a higher risk of dyslipidemia in humans (adjusted multiple logistic regression) (OR 1.93, 95% CI 1.36 to 2.73).

    “hypertension (OR: 1.93, 95% CI 1.36 to 2.73), and body mass index (OR: 1.06, 95% CI 1.01 to 1.2) were positively associated.”

    Humansadjusted multiple logistic regression

    Prevalence of dyslipidaemia and low-density lipoprotein cholesterol target attainment: a descriptive cross-sectional study among adults in the Western Province of Sri Lanka

    BMJ open

  8. Dyslipidemia is linked with a higher risk of hypertension in humans (PR = 1.57).

    “hypertension was significantly associated with older age, kidney disease (PR = 2.05), obesity (PR = 1.72), dyslipidemia (PR = 1.57), diabetes (PR = 1.34), and ever smoking (PR = 1.19).”

    Humans

    Prevalence and risk factors of hypertension in Saudi Arabia based on a nationally representative survey

    Frontiers in cardiovascular medicine

  9. Hypertension is linked with a higher risk of dyslipidemia in humans (OR = 1.238).

    “abnormal blood glucose (OR = 1.365), and hypertension (OR = 1.238) were also significant risk factors for dyslipidemia.”

    Humans

    Analysis of the current situation and influencing factors of dyslipidemia among adults in Guangzhou based on a cross-sectional survey

    Medicine

  10. Dyslipidemia is associated with hypertension in humans (Multiple logistic regression) (AOR 2.8, 95% CI 1.2–7.2; p = 0.024).

    “Dyslipidemia, abdominal obesity and family history were significant predictors of hypertension in this cohort”

    HumansMultiple logistic regressionn = 108

    Vitamin D status and cardiometabolic risk factors among hypertensive and normotensive adults: a hospital-based cross-sectional study in Nepal

    BMC nutrition

All 16

More on Hypertension

Diabetes mellitus

upin humans12OR 1.568–3.945

12 studies
  1. Diabetes mellitus is linked with a higher risk of dyslipidemia in humans (sex-stratified models).

    “hypertension, diabetes, and abdominal obesity were consistently associated with higher odds of dyslipidemia in both sexes.”

    Humanssex-stratified modelsn = 7,803

    Sex-Specific Prevalence and Associated Factors of Dyslipidemia in Korean Adults: A Cross-Sectional Study

    Health science reports

  2. Diabetes mellitus is associated with dyslipidemia in humans.

    “Younger age, female sex, sedentary lifestyle, obesity, hypertension, and diabetes were associated with dyslipidemia.”

    Humansbloodn = 23,665

    Prevalence of dyslipidemia in India: The ICMR-INDIAB National Study (ICMR-INDIAB-25)

    Journal of clinical lipidology

  3. Diabetes mellitus is associated with dyslipidemia in humans (postmenopausal women aged 65 years or younger) (p < .001).

    “diabetes mellitus (p < .001)”

    Humanspostmenopausal women aged 65 years or youngerfemales

    Factors Associated with Dyslipidemia among Korean Postmenopausal Women: Analysis of the 2023 KNHANES IX-2

    Asia-pacific Journal of Convergent Research Interchange

  4. Diabetes mellitus is linked with a higher risk of dyslipidemia in humans (OR=1.568, 95%CI: 1.230-1.998).

    “Additionally, individuals with diabetes or hypertension had a 56.8% (OR=1.568, 95%CI: 1.230-1.998) and 47.7% (OR=1.477, 95%CI: 1.299-1.679) higher risk for dyslipidaemia, respectively”

    Humansn = 5,433

    Analysis on dyslipidemia and influencing factors in middle-aged and elderly people in Hainan Province

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  5. Dyslipidemia is associated with diabetes mellitus in humans (History of dyslipidemia; population-based survey in Duhok City, Iraq).

    “factors associated with diabetes included older age, higher body mass index, a history of dyslipidemia, and a family history of diabetes.”

    HumansHistory of dyslipidemia; population-based survey in Duhok City, Iraqn = 563

    Prevalence and Risk Factors of Diabetes and Prediabetes: A Population-Based Survey

    Galician Medical Journal

  6. Dyslipidemia is associated with diabetes mellitus in adults with hypertension (AOR 1.83, 95% CI 1.23-2.72).

    “and dyslipidemia (1.83, 1.23-2.72).”

    Humansin adults with hypertension

    Prevalence of diabetes/prediabetes and their associated risk factors among adults with hypertension from iran: a nationwide study

    Scientific reports

  7. Dyslipidemia is associated with diabetes mellitus in humans (prediabetes at diagnosis).

    “Dyslipidaemia, with higher triglyceride levels and lower high-density lipoprotein levels at diagnosis, was more prevalent among the participants who progressed to DM.”

    Humansprediabetes at diagnosis2-year follow-upn = 705

    Epidemiological features and prevalence patterns of prediabetes outcomes in an east coast Malaysian cohort: A retrospective cohort study

    Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia

  8. Dyslipidemia is linked with a higher risk of diabetes mellitus in humans (Chinese adults) (OR 1.94).

    “dyslipidemia (1.94)”

    HumansChinese adults

    Estimating the burden of adult diabetes in China: a systematic review and meta-analysis with attributable risk assessment

    BMC public health

  9. Dyslipidemia is linked with a higher risk of diabetes mellitus in humans (OR = 3.945; 95%CI: 3.254, 4.783).

    “Dyslipidemia was a significant risk factor for developing diabetes (OR = 3.945; 95%CI: 3.254, 4.783)”

    Humans

    Association analysis of factors influencing psychosomatic diseases among middle-aged and elderly people in China

    Journal of affective disorders

  10. Diabetes mellitus is linked with a higher risk of dyslipidemia in humans (OR = 2.28, 95% CI: 1.96, 2.66).

    “diabetes mellitus (OR = 2.28, 95%CI: 1.96, 2.66)”

    Humansn = 5,197

    Prevalence and associated factors of dyslipidemia in elderly people: Results from the Ardakan Cohort Study on Ageing, Iran

    PloS one

All 12

More on Diabetes mellitus

Obesity

upin humans9OR 1.22–3.389

9 studies
  1. Obesity is associated with dyslipidemia in humans (AOR 4.24 (95% CI: 2.34-7.66)).

    “obesity (AOR = 4.24, 95% CI: 2.34-7.66), and presence of hypertension (AOR = 1.81, 95% CI: 1.14-2.90) were independently associated with increased odds of dyslipidemia.”

    Humans

    Prevalence of Dyslipidemia and Associated Factors Among Adult Outpatients at Jimma Medical Center, Southwest Ethiopia: A Cross-Sectional Study

    Health science reports

  2. Obesity is linked with a higher risk of dyslipidemia in humans (obesity compared with normal weight) (aOR 1.86 (95% CI 1.60–2.16)).

    “1.86 (95% CI 1.60–2.16) for obesity”

    Humansobesity compared with normal weight

    Epidemiological Characteristics of Dyslipidemia and Its Associat ion with Obesity among Chinese Adults Aged 40 Years and Ol der

    Research SquarePreprint

  3. Obesity is associated with dyslipidemia in humans (compared with patients of normal weight) (OR = 2.26 (95% CI: 1.59-3.21)).

    “overweight (OR = 1.75, 95% CI: 1.33-2.30) and obesity (OR = 2.26, 95% CI: 1.59-3.21) were positively associated with dyslipidemia.”

    Humanscompared with patients of normal weightn = 1,145

    Association between BMI and dyslipidemia in patients with severe mental disorders: An electronic health record study

    Digital health

  4. Obesity is linked with a higher risk of dyslipidemia in humans (OR = 3.389).

    “Overweight (OR = 1.952) or obesity (OR = 3.389), abnormal blood glucose (OR = 1.365), and hypertension (OR = 1.238) were also significant risk factors for dyslipidemia.”

    Humans

    Analysis of the current situation and influencing factors of dyslipidemia among adults in Guangzhou based on a cross-sectional survey

    Medicine

  5. Obesity is linked with a higher risk of dyslipidemia in humans after adjusting for confounding factors (OR 2.81 (95% CI 1.78-4.43)).

    “adjusted odds ratios (ORs) (95% confidence intervals [CIs]) for dyslipidemia in obese men and women were 1.32 (0.90-1.94) and 2.81 (1.78-4.43).”

    Humansafter adjusting for confounding factors5 yearsfemales

    Comparison of the 5-Year Incidence of Dyslipidemia in the Obese and Nonobese Adult Population: Results of the Yazd Health Study (YaHS)

    Advanced biomedical research

  6. Obesity is linked with a higher risk of dyslipidemia in humans (OR = 1.22, 95% CI: 1.05-1.42).

    “both obesity (odds ratio [OR] = 1.22, 95% CI: 1.05-1.42) and abdominal obesity (OR = 1.23, 95% CI: 1.11-1.36) were positively associated with dyslipidemia”

    Humansn = 11,561

    Association Between Obesity and Dyslipidemia Among Adults in Three Counties (Cities) of Sichuan Province

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

  7. Obesity is associated with dyslipidemia in humans (Menopausal women) (AOR 3.08, 95% CI 1.14–8.34).

    “Independent of age, decreased estrogen levels, physical inactivity, and being obese were significant predictors of adverse lipid changes.”

    HumansMenopausal womenfemales

    Prevalence of dyslipidemia and associated factors among premenopausal and post-menopausal women: a community-based comparative cross-sectional study in Debre Markos city, Northwest, Ethiopia, 2024

    BMC endocrine disorders

  8. Obesity is linked with a higher risk of dyslipidemia in humans (rural North-Indian population) (P < 0.005).

    “Obesity possesses significant risk of Dyslipidemia, Hypertension, and Diabetes independently (P < 0.005).”

    Humansrural North-Indian populationn = 456

    Health Risk Associated with Obesity in North Indian Rural Population: Population Based Survey

    Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine

  9. Obesity is linked with a higher risk of dyslipidemia in humans (Model three g, obesity vs normal) (OR 2.82, 95% CI 2.42–3.27).

    “BMI levels with prevalence of dyslipidemia: overweight vs normal, 2.06 (95%CI 1.86, 2.27); obesity vs normal, 2.82(95% CI 2.42, 3.27)”

    HumansModel three g, obesity vs normaln = 9,427

    Individual and Combined Effect of Famine Exposure and Obesity Parameters on Dyslipidemia in Mid-Aged and Older Adult: A Population-Based Cross-Sectional Study

    Research SquarePreprint

More on Obesity

Age

upin humans4mixedin humans2OR 1.037–1.058

6 studies
  1. Age is associated with dyslipidemia in humans (China) (Risk peaked in the mid-50s).

    “Results reveal a nonlinear age pattern, with dyslipidemia risk peaking in the mid-50 s before declining in later life.”

    HumansChina2011–2020

    Diagnosed blood fat disorder linked to environment in China

    Journal of urban health : bulletin of the New York Academy of Medicine

  2. Age is associated with dyslipidemia in humans (postmenopausal women aged 65 years or younger) (p = .007).

    “Factors significantly associated with dyslipidemia among postmenopausal women included age group (p = .007),educational level (p = .048)”

    Humanspostmenopausal women aged 65 years or youngerfemales

    Factors Associated with Dyslipidemia among Korean Postmenopausal Women: Analysis of the 2023 KNHANES IX-2

    Asia-pacific Journal of Convergent Research Interchange

  3. Age is associated with dyslipidemia in humans (patients attending a specialized endocrinology and diabetes clinic).

    “Middle‐aged adults carried the greatest burden of abnormal triglycerides and LDL‐C”

    Humanspatients attending a specialized endocrinology and diabetes clinic

    The High Burden of Dyslipidemia in Ibb, Yemen: A Retrospective Analysis From 2018 to 2026 of Gender and Age Associations in 14,691 Individuals

    Cureus

  4. Age is linked with a higher risk of dyslipidemia in humans (OR=1.037, 95%CI: 1.029-1.044).

    “for each 1 year increase of age (with the baseline age of 35 years), the risk for dyslipidaemia increased by 3.7% (OR=1.037, 95%CI: 1.029-1.044)”

    Humansn = 5,433

    Analysis on dyslipidemia and influencing factors in middle-aged and elderly people in Hainan Province

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  5. Age is associated with dyslipidemia in humans (Perimenopausal and postmenopausal women).

    “Age and duration since menopause showed significant association with dyslipidemia, while BMI and menopausal status did not.”

    HumansPerimenopausal and postmenopausal womenfemalesn = 257

    Study of serum lipid profile in relation to menopausal status and body mass index in a tertiary care hospital

    International Journal of Clinical Obstetrics and Gynaecology

  6. Age is linked with a higher risk of dyslipidemia in humans (hospital employee physical examinations) (OR 1.058, 95% CI 1.013-1.105).

    “for each one-year increase in age, the odds of developing dyslipidemia increase by 5.8% (OR,1.058,95%CI,1.013-1.105)”

    Humanshospital employee physical examinationsfemalesn = 207

    Body composition and dyslipidemia in postmenopausal medical workers: a cross-sectional study

    BMC women's health

Smoking

upin humans6OR 1.245–1.929

6 studies
  1. Smoking is linked with a higher risk of dyslipidemia in humans (multivariable logistic regression) (OR 1.929).

    “Current smoking was associated with dyslipidemia for men (OR, 1.929) and women (OR, 1.471).”

    Humansmultivariable logistic regressionmalesn = 7,803

    Sex-Specific Prevalence and Associated Factors of Dyslipidemia in Korean Adults: A Cross-Sectional Study

    Health science reports

  2. Smoking is linked with a higher risk of dyslipidemia in humans (moderate and severe pre-cessation dependence in former smokers) (AOR=1.77 and 1.89).

    “and dyslipidemia (AOR=1.77 and 1.89).”

    Humansmoderate and severe pre-cessation dependence in former smokersn = 1,935

    Tobacco dependence severity, cessation legacy and serial mediation in aging China

    Tobacco induced diseases

  3. Smoking is linked with a higher risk of dyslipidemia in humans (OR=1.245, 95%CI: 1.061-1.460).

    “Occasional or regular smokers had a 24.5% (OR=1.245, 95%CI: 1.061-1.460) higher risk compared with non-smokers or former smokers.”

    Humansn = 5,433

    Analysis on dyslipidemia and influencing factors in middle-aged and elderly people in Hainan Province

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  4. Smoking is linked with a higher risk of dyslipidemia in current heavy smokers and former heavy smokers vs never-smokers (P < 0.001).

    “The risk of diabetes, dyslipidemia, and hypertension in current heavy smokers and former heavy smokers were higher than that in never-smokers (all P < 0.001).”

    Humansin current heavy smokers and former heavy smokers vs never-smokersn = 78,674

    Connection of smoking with risks of dyslipidemia, diabetes, and hypertension among adults in Northeast China: a cross-sectional study

    BMC public health

  5. Smoking is associated with dyslipidemia in humans (rheumatoid arthritis).

    “Age, body mass index (BMI), female gender, smoking history, glucocorticoid use, and higher DAS28 were identified as independent risk factors for dyslipidemia.”

    Humansrheumatoid arthritisn = 312

    Clinical characteristics and risk factors of dyslipidemia in patients with rheumatoid arthritis

    Immunobiology

  6. Smoking is linked with a higher risk of dyslipidemia in humans.

    “Smoking and alcohol consumption increase the risk.”

    Humansn = 13,354

    Nonlinear associations between environmental factors and lipid levels in middle-aged and elderly population in China: A national cross-sectional study

    The Science of the total environment

More on Smoking

Cardiovascular disease

upin humans4upin reviews1OR 1.227

5 studies
  1. Dyslipidemia is linked with a higher risk of cardiovascular disease in humans (OR 1.227 (95% CI 1.11–1.33)).

    “dyslipidaemia (OR 1.227; 95%CI 1.11–1.33)”

    Humansfemales

    Sex-Specific Cardiovascular Risk Phenotypes Integrating Cardiometabolic, Psychosocial, and Autoimmune Determinants: A Population-Based Cross-sectional Study

    Research SquarePreprint

  2. Dyslipidemia is linked with a higher risk of cardiovascular disease in humans.

    “we found significant association between traditional CVD risk factors, such as hypertension and dyslipidemia, and CVD onset.”

    Humans

    Establishment of Ascertainment Methods for Cardiovascular Disease Onset in the Tohoku Medical Megabank Organization

    Circulation reports

  3. Dyslipidemia raises the risk of cardiovascular disease in humans.

    “dyslipidemia—a multifaceted metabolic state characterized by pathologically elevated lipid concentrations—functions as a primary driver in the pathogenesis of atherosclerosis and subsequent cardiovascular disease.”

    Review

    Sexual Dimorphism and Aging as Determinants of Serum Lipid Profiles and Cardiovascular Risk

    Journal of Education Health and Sport

  4. Dyslipidemia raises the risk of cardiovascular disease.

    “Dyslipidemia remains a central modifiable risk factor for cardiovascular disease”

    Review

    Lipid-lowering therapies: the arrows in the quiver and future bullets

    Minerva cardiology and angiology

  5. Dyslipidemia raises the risk of cardiovascular disease in humans.

    “Dyslipidemia is a well-established risk factor for CVD”

    Review

    Aging and dyslipidemia: a review of potential mechanisms

    Ageing research reviews

More on Cardiovascular disease

Alcohol

upin humans3downin humans1OR 2.667

4 studies
  1. Alcohol is linked with a lower risk of dyslipidemia in humans (sex-stratified models).

    “Alcohol intake was inversely associated with dyslipidemia only in men.”

    Humanssex-stratified modelsmalesn = 7,803

    Sex-Specific Prevalence and Associated Factors of Dyslipidemia in Korean Adults: A Cross-Sectional Study

    Health science reports

  2. Alcohol is associated with dyslipidemia in humans (Pamirs Plateau residents).

    “Male, non-minority, older age, diabetes, frequent alcohol consumption, and higher education were significantly associated with dyslipidemia.”

    HumansPamirs Plateau residentsfrequent2021–2024

    A serial 4-year cross-sectional study of dyslipidemia on Pamirs Plateau, the roof of the world

    BMC medicine

  3. Alcohol is associated with dyslipidemia in humans (OR = 2.667 for TC, OR = 1.919 for LDL, OR = 3.412 for TG).

    “Alcohol consumption was associated with dyslipidaemia (OR = 2.667, P < 0.01 for TC; OR = 1.919, P < 0.05 for LDL; OR = 3.412, P < 0.01 for TG)”

    Humansn = 438

    Effect of the interaction between alcohol and meat consumption on the hyperlipidaemia risk among elderly individuals: Evidence from Shanghai, China

    Frontiers in nutrition

  4. Alcohol is linked with a higher risk of dyslipidemia in humans.

    “Smoking and alcohol consumption increase the risk.”

    Humansn = 13,354

    Nonlinear associations between environmental factors and lipid levels in middle-aged and elderly population in China: A national cross-sectional study

    The Science of the total environment

More on Alcohol

Sarcopenic obesity

upin humans4OR 1.5–4.15

4 studies
  1. Dyslipidemia is associated with sarcopenic obesity in humans (Mexican adults; multivariable model) (OR = 2.492, P = .044).

    “and history of dyslipidemia (OR = 2.492, P = .044).”

    HumansMexican adults; multivariable model

    Risk Factors for Sarcopenic Obesity in Adults: A Case-Control Study Using Bioelectrical Impedance Analysis

    AACE endocrinology and diabetes

  2. Sarcopenic obesity is associated with dyslipidemia in humans (males, sarcopenic obesity vs normal group) (OR 4.15 vs normal group).

    “In males, the odds ratios (ORs) of osteoporosis and dyslipidemia in the SO group were 4.21-fold and 4.15-fold higher than those in the normal group, respectively.”

    Humansmales, sarcopenic obesity vs normal groupmales

    Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria

    BMC endocrine disorders

  3. Sarcopenic obesity is associated with dyslipidemia in humans (OR 1.50 versus non-sarcopenia group).

    “while the ORs of dyslipidemia was increased by 1.12 and 1.50, respectively”

    Humans

    Association between Sarcopenia, Sarcopenic Obesity, and Chronic Disease in Korean Elderly

    Journal of bone metabolism

  4. Sarcopenic obesity raises the risk of dyslipidemia in humans (compared with non-SO) (OR 2.50, 95% CI 1.51-4.15).

    “dyslipidaemia (k = 3; OR = 2.50; 95% CI: 1.51-4.15)”

    Reviewcompared with non-SO

    Sarcopenic obesity and health outcomes: An umbrella review of systematic reviews with meta-analysis

    Journal of cachexia, sarcopenia and muscle

More on Sarcopenic obesity

Telomere length

downin humans3upin humans1OR 0.563

4 studies
  1. Dyslipidemia is associated with telomere length in dyslipidaemic individuals.

    “Diabetic and dyslipidaemic groups had shorter telomeres than the control group.”

    Humansin dyslipidaemic individuals

    Investigation of the Characteristics of Telomere Length in Koreans and Its Association With Chronic Metabolic Disorders: A Comprehensive Study

    Journal of cellular and molecular medicine

  2. Dyslipidemia is associated with telomere length in humans (Patients without cardiovascular diseases).

    “support an association with dyslipidemia in premature shortening of telomere length.”

    HumansPatients without cardiovascular diseasesleukocyten = 45

    Telomere Length in Young Patients: Relationship With Metabolic Syndrome and Its Components

    Journal of clinical medicine research

  3. Telomere length is linked with a lower risk of dyslipidemia in PCOS patients (OR: 0.563; 95% CI: 0.450-0.968; p = 0.042).

    “Longer rLTL was associated with reduced risk of dyslidpidemia (OR: 0.563; 95% CI: 0.450-0.968; p = 0.042) in PCOS patients.”

    Humansin PCOS patientsfemales

    Shortened Relative Leukocyte Telomere Length Is Associated With Polycystic Ovary Syndrome and Metabolic Traits

    Endocrinology, diabetes & metabolism

  4. Telomere length is associated with dyslipidemia in humans (characterised by high LDL-C).

    “logistic regression showed a significant association between Log10LTL and prevalent dyslipidaemia characterised by high LDL-C”

    Humanscharacterised by high LDL-Cn = 676

    Cardiometabolic profile and leukocyte telomere length in a Black South African population

    Scientific reports

More on Telomere length

Sarcopenia

upin humans4OR 1.47–3.09

4 studies
  1. Dyslipidemia is associated with sarcopenia in humans (p = 0.004).

    “Correlation analysis revealed a positive association between sarcopenia and BMI, insulin resistance, high triglyceride levels, and the presence of dyslipidaemia”

    Humansn = 135

    Are Hyperlipidaemia and Insulin Resistance Risks For Sarcopenia?

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

  2. Dyslipidemia is associated with sarcopenia in humans (OR 1.47).

    “The overall OR of the relationship between sarcopenia and dyslipidemia was 1.47”

    Humans

    Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis

    BMC geriatrics

  3. Dyslipidemia is associated with sarcopenia in humans.

    “hypertension and dyslipidemia, but not diabetes, were found to be significantly associated with sarcopenia”

    Humans

    Circulating miR-29b decrease in response to sarcopenia in patients with cardiovascular risk factors in older Chinese

    Frontiers in cardiovascular medicine

  4. Sarcopenia is associated with dyslipidemia in patients with rheumatoid arthritis (OR 3.09, 95% CI 1.37-6.99).

    “sarcopenia was associated with obesity (OR 2.61, 95% CI 1.42-4.83), dyslipidemia (3.09, 1.37-6.99)”

    Humansin patients with rheumatoid arthritis

    Association between sarcopenia defined as low lean mass by dual-energy X-ray absorptiometry and comorbidities of rheumatoid arthritis: Results of a nationwide cross-sectional health examination

    Seminars in arthritis and rheumatism

More on Sarcopenia

Treatment discontinuation

downin humans1upin humans1OR 0.53

1 study
  1. Dyslipidemia predicts treatment discontinuation in the TPTD group (OR: 0.53, 95% CI: 0.29–0.99, p = 0.05).

    “In the TPTD group, dyslipidemia and calcium levels were significantly associated with adherence-related discontinuation (odds ratio [OR]: 0.53, 95% CI: 0.29–0.99, p = 0.05; OR: 0.54, 95% CI: 0.30–0.96, p = 0.03, respectively).”

    Human trialin the TPTD group120 weeks

    Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05

    Journal of bone and mineral metabolism

  2. Dyslipidemia predicts treatment discontinuation in humans (adherence-related TPTD discontinuation).

    “Dyslipidemia and serum calcium levels were significant predictors of TPTD discontinuation”

    Human trialadherence-related TPTD discontinuation

    Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05

    Journal of bone and mineral metabolism

Glutathione

downin humans1

1 study
  1. Glutathione is associated with dyslipidemia in humans.

    “Associated benefits included improvements in insulin sensitivity, body composition, anthropometry, muscle strength, and dyslipidemia.”

    Human trial14 daysmalesn = 8

    Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients

    The Journal of clinical endocrinology and metabolism

More on Glutathione

All 283

Trial sponsors

Funding

8 grants since 2018

National Heart, Lung, and Blood Institute$6.9MFWF Austrian Science Fund€448KNational Institute of Diabetes and Digestive and Kidney Diseases$87.5K

Latest

Journal of Urban Health

Diagnosed blood fat disorder linked to environment in China

Across five survey waves from 2011–2020, environmental links to diagnosed blood fat disorders were stronger among earlier-born middle-aged and older adults in China.Across five survey waves from 2011–2020, environmental links to diagnosed blood fat disorders were stronger among earlier-born middle-aged and older adults in China.

Cohort studyPopulations

See all 3,191 papers on dyslipidemia